|
141 |
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
Enthalten in Breast cancer research Bd. 9, 26.10.2007, Nr. 5, date:10.2007: 1-8
|
|
|
|
142 |
Dokumentationsaufwand und verbundene Ressourcen bei Patientinnen mit einem primären Mammakarzinom – von der Primärdiagnose bis zur Abschluss der Nachsorge – Ergebnisse der multizentrischen Erhebung
Enthalten in Das Gesundheitswesen Bd. 78, 2016, Nr. 07: e52-e52
|
|
|
|
143 |
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
Enthalten in Breast cancer research Bd. 10, 15.9.2008, Nr. 5, date:10.2008: 1-8
|
|
|
|
144 |
Erratum to: Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1
Enthalten in Breast cancer research Bd. 11, 13.1.2009, Nr. 1, date:6.2009: 1
|
|
|
|
145 |
Evaluation of sonographic detectability of different markers within an in vitro simulation model of the axilla
Enthalten in Archives of gynecology and obstetrics Bd. 304, 17.6.2021, Nr. 3, date:9.2021: 839-848
|
|
|
|
146 |
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
Enthalten in Breast cancer research Bd. 14, 20.1.2012, Nr. 1, date:2.2012: 1-9
|
|
|
|
147 |
Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma
Enthalten in BMC cancer Bd. 11, 28.1.2011, Nr. 1, date:12.2011: 1-10
|
|
|
|
148 |
Fertility-conserving treatment of early stage cervical cancer using trachelectomy and laparoscopic lymphadenectomy-a case report and a review of recent literature
Enthalten in Gynecological surgery Bd. 5, 15.8.2007, Nr. 2, date:5.2008: 143-146
|
|
|
|
149 |
Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany
Enthalten in BMC cancer Bd. 20, 11.11.2020, Nr. 1, date:12.2020: 1-13
|
|
|
|
150 |
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study
Enthalten in BMC cancer Bd. 19, 21.6.2019, Nr. 1, date:12.2019: 1-9
|
|
Administration
